Global Blood Therapeutics | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
Oct 5, 2022 16:32 ET
Global Blood Therapeutics | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
Oct 5, 2022 16:27 ET
Global Blood Therapeutics | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
Oct 5, 2022 16:21 ET
Global Blood Therapeutics | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Oct 5, 2022 08:59 ET
Global Blood Therapeutics | PREM14A: Preliminary proxy statements relating to merger or acquisition
Aug 19, 2022 16:16 ET
No Data
No Data